Nisen Perry
SEC insider (Form 3/4/5 filer). CIK 0001683791. Director at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in TEL AVIV.
Companies Nisen Perry has filed insider reports for
- TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): Director
Nisen Perry
CIK: 0001683791
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 5, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
ExerciseDirect14.5K shares- - May 28, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
AwardDirectRestricted Share Units
7.2K shares- - Jun 6, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
ExerciseDirect9.6K shares- - Jun 5, 2025TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
AwardDirectRestricted Share Units
14.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise | 14,492 | - | $0 | Direct |
| May 28, 2026 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award Restricted Share Units | 7,242 | - | - | Direct |
| Jun 6, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Exercise | 9,632 | - | - | Direct |
| Jun 5, 2025 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | Award Restricted Share Units | 14,492 | - | - | Direct |
1-4 of 4 transactions